摘要 |
The present invention provides compounds of formula I <CHEM> wherein R<1> is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R<2> is C1-C6 alkyl or C5-C7 cycloalkyl which is optionally substituted with 1 to 3 substitutents selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, hydroxy, amino, nitro, and halo; X is -CH(OH)- or -CH2-; M is -CH2CH2- or -CH=CH-; n is 2 or 3; and R<3> is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Also provided are methods of using the compounds of the present invention for the treatment of various medical indications associated with post-menopausal syndrome, uterine fibroid disease, endometriosis, and aortal smooth muscle cell proliferation. The present invention further provides pharmaceutical compositions of compounds of formula I, as well, as intermediate compounds for the preparation thereof. |